Truxima ( FDA Approved Biosimilar targets CD20)

[markt]

https://www.centerforbiosimilars.com/news/fda-approves-celltrions-rituximab-biosimilar-truxima

Thought this may be interesting for some of us currently on Rituximab. 

- Mark

[Sharon]

"Notably, while the reference rituximab also carries indications for inflammatory diseases including rheumatoid arthritis, Celltrion sought approval only for indications in oncology."

-Does this mean it can't be prescribed for autoimmunes as well?

[markt]

Yes, no, maybe?

In the long run it may be a viable treatment if the biosimilar is essentially as efficous as Rituximab. 

Short term probably for NHL only.  Something I intend to ask about though.